Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
All articles — 31945 total
AXON enters September with the full July rally unwound and the market asking whether the August 5 earnings selloff was an overreaction or a fair verdict on a stock that had run too far. The price action tells a blunt…
Vivmark Residential heads into the first week of September with a sharp reversal in insider behaviour — the cluster of buyers flagged just days ago has given way to a wave of sales across senior management. The shift…
Scribe Therapeutics enters September in a peculiar position — the stock has shed 7% on the week and 5% in a single session, yet four analyst initiations and a cluster of insider buying tell a sharply different story…
Securitize Corp. enters its September 4 earnings report in an unusual position — short sellers have pulled back sharply over the past week, yet the borrow market remains tight and the stock has shed 7% in seven…
WhiteHawk Minerals Corp. heads into September with a fresh analyst upgrade pulling in one direction and a steady build in short positions pulling in the other. The most immediate catalyst is the analyst desk. Raymond…
ERock, Inc. heads into September with an awkward split: the stock fell 12% on the week to $11.41, yet every analyst on the Street carries a buy-equivalent rating with a mean target of $22.50 — nearly double where…
TRAX — First Tracks Biotherapeutics — has shed nearly 9% in a week despite one of the most bullish analyst postures of any small-cap biotech on Nasdaq, making the gap between Street conviction and price action the…
AVEX enters September on the back foot — down 4% on Tuesday and off 3.2% for the week to $16.89 — with a fresh analyst initiation setting a target barely above the current price, even as the rest of the Street sits…
Liftoff Mobile enters September with a sharp divergence between its options market — now flashing the most defensive signal in its brief public history — and a Street consensus that remains firmly constructive,…
MiniMed Group has delivered a sharp reversal from the cautious pre-earnings setup documented in recent notes: the stock has rallied 18.5% on the week and the Street has moved in unison to lift targets, even as short…
PURR has shifted from one of the most charged short-side setups in small-cap to something that looks more like an orderly retreat — shorts are covering, availability is flooding back, and the stock is giving ground…
ADBT has shed 41% in a single week — a violent move in a stock where the entire tradeable float fits in a thimble. The borrow market tells the sharpest short-term story. Cost to borrow has nearly doubled in five…
CDNL is navigating one of its sharpest drawdowns since going public, with the stock off 17% on the week and 42% over the past month — a collapse that followed a brutal August 11 earnings print and has left the market…
BillionToOne enters September navigating its sharpest monthly correction since listing, with analysts recalibrating targets and short sellers quietly adding exposure into the weakness. The month-to-date story is stark.…
Navan, Inc. heads into its September 9 earnings release with short sellers adding exposure at the fastest pace in months — even as options traders remain conspicuously bullish. Short interest has climbed 16% over the…
PSKY heads into September carrying a sharp contradiction: the stock has rallied 33% in a month, yet the Street's unanimous verdict is sell, and short sellers are only slowly backing away. The positioning picture is…
AIPO — the Defiance AI & Power Infrastructure ETF — enters September with a striking contradiction at its core: short sellers have been aggressively unwinding positions, yet options traders remain deeply defensive. The…
NIQ Global Intelligence enters September with a peculiar double character: a stock that more than doubled on a single earnings day is now pulling back, while nearly every short-selling indicator has simultaneously…
Amrize AG heads into the final stretch of summer with a striking insider buying cluster — four executives purchasing shares in a three-day window — even as the stock extends its steepest monthly decline since the…
CRWV fell another 7% this week to $81.85, extending the pullback that was already in motion when the previous note published — and this time, the most telling data point isn't the options market. It's the CEO's own…
